By the same authors

From the same journal

Impact of HIV drug resistance on HIV/AIDS associated mortality, new infections and antiretroviral therapy program costs in sub-Saharan Africa

Research output: Contribution to journalArticle

Author(s)

  • Andrew N Phillips
  • John Stover
  • Valentina Cambiano
  • Fumiyo Nakagawa
  • Michael R Jordan
  • Deenan Pillay
  • Meg Doherty
  • Paul Revill
  • Silvia Bertagnolio

Department/unit(s)

Publication details

JournalThe Journal of Infectious Diseases
DatePublished - 17 Feb 2017
Original languageEnglish

Abstract

To inform the level of attention to be given by antiretroviral therapy (ART) programs to HIV drug resistance (HIVDR), we used an individual-level model to estimate its impact on future AIDS deaths, HIV-incidence and ART program costs in sub-Saharan Africa (SSA) for a range of program situations. We applied this to SSA through the Spectrum-Goals model. In a situation in which current levels of pre-treatment HIVDR are over 10% (mean 15%), 16% of AIDS deaths (890,000 deaths) , 9% of new infections (450,000) and 8% ($6.5 billion) of ART program costs in SSA in 2016-2030 will be attributable to HIVDR.

Bibliographical note

© The Author 2017. This is an author-produced version of the published paper. Uploaded in accordance with the publisher’s self-archiving policy. Further copying may not be permitted; contact the publisher for details

    Research areas

  • Journal Article

Discover related content

Find related publications, people, projects, datasets and more using interactive charts.

View graph of relations